Results 31 to 40 of about 22,534,193 (360)

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

open access: yesScience Translational Medicine, 2019
Tumor organoids from individual patients with metastatic colorectal cancer can help predict response to irinotecan with or without 5-fluorouracil. Dishing out treatment recommendations The number of treatment options for cancer patients keeps expanding ...
S. Ooft   +22 more
semanticscholar   +1 more source

SPECIAL ISSUE : "Integrative medicine in oncology: another step forward" - PATIENTS ADVOCACY: MORE THAN A SIMPLY REPRESENTATIVE DEFENSE

open access: yesJournal of Cancer Rehabilitation, 2021
Italian legislation has included citizens’ active participation and voluntary associations in the phases of planning and evaluation of health-related services.
Carmela Amato   +4 more
doaj   +1 more source

All-cause mortality following a cancer diagnosis amongst multiple sclerosis patients: A Swedish population-based cohort study [PDF]

open access: yes, 2015
Background and purpose: A reduced cancer risk amongst patients with multiple sclerosis (MS) has been reported. Theoretically, this could represent a genuine reduction in risk or, alternatively, 'diagnostic neglect', where cancer is undiagnosed when ...
Bahmanyar, S.   +4 more
core   +1 more source

Nutrition in Cancer Patients [PDF]

open access: yesJournal of Clinical Medicine, 2019
Background: Despite being recognised that nutritional intervention is essential, nutritional support is not widely accessible to all patients. Given the incidence of nutritional risk and nutrition wasting, and because cachexia management remains a challenge in clinical practice, a multidisciplinary approach with targeted nutrition is vital to improve ...
openaire   +3 more sources

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

open access: yesInternational Journal of Gynecological Cancer, 2023
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with ...
D. Cibula   +26 more
semanticscholar   +1 more source

Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker. [PDF]

open access: yes, 2018
Though bladder urothelial carcinoma is the most common form of bladder cancer, advances in its diagnosis and treatment have been modest in the past few decades.
Li, Wei Tse   +4 more
core   +2 more sources

OPIOIDS IN PAIN SYNDROME MANAGEMENT (part 1)

open access: yesВестник анестезиологии и реаниматологии, 2018
The goal of this review is to inform doctors about new opioids currently used for routine medical practice in the most developed countries. This publication contains brief history, describes main mechanisms of opioid action, types and specific ...
D. M. Arbuck   +2 more
doaj   +1 more source

A population-based study of cardiovascular disease mortality risk in US cancer patients.

open access: yesEuropean Heart Journal, 2019
AIMS This observational study characterized cardiovascular disease (CVD) mortality risk for multiple cancer sites, with respect to the following: (i) continuous calendar year, (ii) age at diagnosis, and (iii) follow-up time after diagnosis. METHODS AND
K. Sturgeon   +7 more
semanticscholar   +1 more source

OPIOIDS IN PAIN SYNDROME MANAGEMENT (part 2)

open access: yesВестник анестезиологии и реаниматологии, 2018
The review continues informing the readers about modern opioids, the first part of the review can be found in the preceding issue. In the light of increased interest towards pain management with opioids, the article will be useful for a broad audience of
D. M. Arbuck   +2 more
doaj   +1 more source

Repurposing metformin for cancer treatment: current clinical studies. [PDF]

open access: yes, 2016
In recent years, several studies have presented evidence suggesting a potential role for metformin in anti-cancer therapy. Preclinical studies have demonstrated several anticancer molecular mechanisms of metformin including mTOR inhibition, cytotoxic ...
Altman, Jessica K   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy